Your fact-checks will appear here
System managed by the CDC and FDA that measures harms from vaccines to ascertain whether the risk-benefit ratio is high enough
Since 2020 there is no single, universally accepted count of deaths “directly linked” to COVID‑19 vaccines; national autopsy-based reviews and regulatory surveillance offer than raw adverse‑event repo...
Available reporting shows an internal FDA review of 96 pediatric death reports to VAERS from 2021–2024 concluded at least 10 of those reports met criteria for “likely, probable, or possible” causal li...
Reported tallies of "deaths from COVID vaccine" vary widely because they mix raw, unverified reports with adjudicated findings; passive surveillance systems like VAERS show tens of thousands of report...
Michael (Mike) Yeadon, a former Pfizer allergy and respiratory research vice president who left the company in 2011, has made repeated claims about Pfizer, COVID-19 vaccines, fertility, children’s saf...
Available mainstream reporting shows a recent internal FDA review concluded that at least 10 children died “after and because of” COVID-19 vaccination based on an analysis of 96 VAERS‑reported pediatr...
As of late April 2024, public downloads of VAERS raw data compiled by independent trackers showed hundreds to over a million COVID‑19–associated reports depending on scope and whether domestic-only da...
Available surveillance and regulatory reports show the 2023–2024 mRNA COVID vaccines had estimated myocarditis/pericarditis incidence of roughly 8 cases per million doses overall and higher rates in y...
Dr. Sanjay Gupta’s COVID-19 commentary has generated disputes over three main areas: his public fights with conservative media figures over vaccine messaging, his appearances on platforms that critics...
CDC systems have flagged a small number of rare adverse events after seasonal influenza vaccination in 2025, most notably Guillain–Barré syndrome (GBS) at an estimated excess risk of about one to two ...
Available studies and regulatory summaries show myocarditis after COVID-19 vaccination is rare, concentrates in males aged ~12–24 and most often occurs within days of a second mRNA dose; FDA cites ~27...
VAERS is a passive reporting system that collects unverified reports of adverse events after vaccination; and public‑health reviews find that confirmed vaccine‑caused deaths are effectively zero or an...
Clinical trials and product information show Prevnar 20 (pneumococcal 20‑valent conjugate vaccine) is generally well tolerated; the most common reactions after a dose are injection‑site pain, muscle p...
There is no single public, consumer-facing Pfizer database that lets you enter a lot number and get full manufacturer records; multiple guidance pages and reporting routes instead point users to vacci...
The preponderance of reports from 2021–2025 shows that the . Large passive-safety datasets and narrative reviews agree that serious neurological adverse events are uncommon relative to vaccine doses a...
The currently recommended shingles vaccine, Shingrix (recombinant zoster vaccine, RZV), has a strong safety and effectiveness record in clinical trials and large real‑world studies, with common short‑...
The official federal stance is mixed: the FDA’s vaccine chief Vinay Prasad circulated an internal memo saying an FDA review of 96 pediatric deaths reported to VAERS “concludes that no fewer than 10 ar...
Norman Fenton, an emeritus professor of risk and information management, has publicly challenged mainstream COVID-19 vaccine effectiveness and safety analyses and says his work has been de‑platformed ...
An internal FDA review of 96 pediatric deaths reported to VAERS from 2021–2024 concluded that “no fewer than 10” deaths were related to COVID-19 vaccination, with staff attributing those deaths primar...
The MMR vaccine has a well-established safety profile: common reactions are mild and transient (fever, rash, injection-site pain), while a small set of rare serious events have been causally linked to...
The evidence collected during and after large-scale COVID-19 vaccination campaigns shows different long-term safety signals for the adenovirus-vector Johnson & Johnson (J&J/Janssen) shot versus the mR...